The Food and Drugs Authority (FDA) has approved R21 malaria vaccine immunization of children aged 5 to 36 months against malaria caused by plasmodium Falciparum.
Ghana is the first country to approve a new malaria vaccine that has been described as a “world-changer” by the scientists who developed it.
The vaccine – called R21 – appears to be hugely effective, in stark contrast to previous ventures in the same field.
Ghana’s drug regulators have assessed the final trial data on the vaccine’s safety and effectiveness, which is not yet public, and have decided to use it.
The World Health Organization is also considering approving the vaccine.
It has been a massive, century-long, scientific undertaking to develop a vaccine that protects the body from the malaria parasite according to BBC
Source:Mybrytfmonline.com/Solomon Nartey
